• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Dyax Corp. (DYAX)

    -NasdaqGM
    14.52 1.06(7.88%) Dec 17, 4:00PM EST
    Add to Portfolio
    Prev Close:13.46
    Open:13.48
    Bid:12.10 x 100
    Ask:N/A
    1y Target Est:14.06
    Beta:0.61
    Earnings Date:Feb 26 - Mar 2 (Est.)
    Day's Range:13.45 - 14.57
    52wk Range:6.05 - 14.69
    Volume:1,285,695
    Avg Vol (3m):1,039,730
    Market Cap:1.98B
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXUp 7.88%1.98B
    SHPG42.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.11
    Quarterly EPS Est (Dec-14) :-0.04
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-6.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback